Skip to content

A study comparing intravenous Ketamine and Lidocaine in reducing pain during Propofol injection.

To compare the efficacy of intravenous Ketamine versus preservative free Lidocaine in alleviating Propofol injection site pain A double blinded randomised control study - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106645
Enrollment
120
Registered
2026-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: PCS-

Interventions

Intervention1: Pretreatment bolus with 1ml 2% preservative free Lidocaine IV: GROUP II will receive pretreatment bolus with 1ml of preservative free 2% Lidocaine. Sixty seconds after pretreatment bol

Sponsors

BGS Global Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients willing to give written informed consent for the study. 2)Patients with BMI 20-24kg/m2. 3)ASA physical status I and II. 4)Day care surgeries where Propofol is used for management. 5)Elective surgeries requiring general anaesthesia using Propofol as induction agent.

Exclusion criteria

Exclusion criteria: 1)Patients who have hypersensitivity to study drugs or its components. 2)Patients with acute or chronic pain syndromes. 3)Patients with history of upper respiratory tract infection/eosinophilia. 4)Patients taking sedatives or analgesics in the past 24 hours. 5)Pregnancy or lactating mothers. 6)History of seizures and / or dystonia. 7)Patients on any psychotropic drugs. 8)Patients with active Psychosis.

Design outcomes

Primary

MeasureTime frame
To grade the injection pain at the local site during Propofol injection for induction of general anaesthesia.Timepoint: 5 Seconds,10 Seconds,15 Seconds,20 Seconds,25 Seconds and 30 Seconds

Secondary

MeasureTime frame
1)Haemodynamic changes after injection of study drug 2)Effect on attenuation of intubation response after injection of study drug, if any. 3)Adverse events during the intraoperative period after the injection of study drug.Timepoint: Haemodynamic changes: 5 seconds, 10 seconds, 15 seconds and 30 seconds Post Intubation response: 0 minutes and 5 minutes

Countries

India

Contacts

Public ContactDr Yoganarasimha N

BGS Global Institute of Medical Sciences

yogaaims@gmail.com9845365348

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026